Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Species differences in carcinogenesis

W Lijinsky1

  • 1Division of Biometry and Risk Assessment, National Institute of Environmental Health Sciences Research Triangle Park, North Carolina 27709.

In Vivo (Athens, Greece)
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of deuterium on the carcinogenicity of nitroso-methyl-n-butylamine.

Carcinogenesis·2012
Same author

Agricultural pesticide use and risk of glioma in Nebraska, United States.

Occupational and environmental medicine·2005
Same author

Agricultural pesticide use and adenocarcinomas of the stomach and oesophagus.

Occupational and environmental medicine·2004
Same author

N-Nitroso compounds in the diet.

Mutation research·1999
Same author

Response to the June 13, 1996, draft report of the Commission on Risk Assessment and Risk Management.

Archives of environmental health·1998
Same author

Studies of initiation and promotion of carcinogenesis by N-nitroso compounds.

Cancer letters·1998
Same journal

Time-Dependent Inflammatory Cytokine Responses in a Human Fetal Membrane Dual-Compartment Model.

In vivo (Athens, Greece)·2026
Same journal

Impact of COVID-19 Vaccine Type on the Efficacy and Safety of Nivolumab in Patients With Metastatic Non-small-cell Lung Cancer: A Multicenter Study.

In vivo (Athens, Greece)·2026
Same journal

Nutritional Support for Treatment Continuity and Survival in Advanced Gastric Cancer: A Propensity Score-matched Study.

In vivo (Athens, Greece)·2026
Same journal

Efficacy of Switching from Prior Nonsteroidal Anti-inflammatory Drugs to Transdermal Diclofenac in Cancer Pain Management.

In vivo (Athens, Greece)·2026
Same journal

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>.

In vivo (Athens, Greece)·2026
Same journal

Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation.

In vivo (Athens, Greece)·2026
See all related articles

Species exhibit varied responses to carcinogens due to metabolic differences. Predicting human carcinogen potency and target organs remains challenging, indicating unknown factors influence inter-species variations.

Area of Science:

  • Toxicology
  • Comparative biology
  • Carcinogenesis

Background:

  • Species-specific responses to carcinogens are well-documented.
  • Variations exist in carcinogen potency, target organs, and resistance across species.
  • Current models struggle to accurately predict human carcinogen effects from animal studies.

Purpose of the Study:

  • To explore the reasons behind inter-species differences in carcinogen response.
  • To highlight the limitations of current methods in predicting human carcinogenicity.
  • To identify potential areas for future research into unknown factors.

Main Methods:

  • Review of existing literature on carcinogen metabolism and activation.
  • Analysis of data on species-specific responses to known carcinogens.

Related Experiment Videos

  • Comparison of DNA alkylation data with observed organ-specific toxicity.
  • Main Results:

    • Metabolism and activation pathways significantly influence carcinogen response variability.
    • Even directly acting carcinogens show unexplained quantitative differences in DNA alkylation and toxicity.
    • Animal studies provide limited predictive power for human carcinogen potency and target organs.

    Conclusions:

    • Inter-species differences in carcinogen response are complex and not fully explained by metabolism or DNA adducts.
    • Unknown biological reactions or interactions are critical determinants of carcinogen effects across species.
    • Further research is needed to elucidate these unknown factors for improved human risk assessment.